← Leaderboards
Charles H Spruck
Sanford Burnham Prebys Medical Discovery Institute
$5,961,722
Attributed
$7,040,710
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,040,710 · 4
By mechanism
R01$7,040,710 · 4
Top collaborators
- Steven H Olson2 shared
- Eduard A. Sergienko2 shared
Most similar at Sanford Burnham Prebys Medical Discovery Institute
Same institution · by research overlap
- Steven H Olson$9,813,239
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingProteinsUbiquitin LigaseGenetic TranscriptionMolecularComplexPreclinical StudyEpigenetic ProcessRetrotransposonPathway InteractionsEndogenous RetrovirusesImmunotherapyMortalityGene SilencingPharmaceutical PreparationsCancer CellDna Replication ForkInhibitorMimicryCytotoxicCancer TherapyNormal CellInfiltrationReplication Stress
Grant awards (16)
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer$809,248
R01 · FY2025 · CA · contact PI
Targeting ER+ Breast Cancer Through Induced Viral Mimicry$446,063
R01 · FY2025 · CA · contact PI
Targeting the FBXO44/SUV39H1 Pathway in Cancer$446,063
R01 · FY2025 · CA · contact PI
Discovery of Potent Selective Inhibitors of the Histone Methyltransferase SUV39H1 for the Treatment of Cancer$809,234
R01 · FY2024 · CA · contact PI
Targeting the FBXO44/SUV39H1 Pathway in Cancer$423,760
R01 · FY2024 · CA · contact PI
Targeting ER+ Breast Cancer Through Induced Viral Mimicry$423,760
R01 · FY2024 · CA · contact PI
Targeting the FBXO44/SUV39H1 Pathway in Cancer$437,141
R01 · FY2023 · CA · contact PI
Targeting ER+ Breast Cancer Through Induced Viral Mimicry$437,141
R01 · FY2023 · CA · contact PI
Targeting ER+ Breast Cancer Through Induced Viral Mimicry$441,716
R01 · FY2022 · CA · contact PI
Targeting the FBXO44/SUV39H1 Pathway in Cancer$441,716
R01 · FY2022 · CA · contact PI
The Role of Cks Proteins in Mammalian Meiosis$373,363
R01 · FY2010 · HD · contact PI
The Role of Cks Proteins in Mammalian Meiosis$235,731
R01 · FY2009 · HD · contact PI
The Role of Cks Proteins in Mammalian Meiosis$145,353
R01 · FY2009 · HD · contact PI
The Role of Cks Proteins in Mammalian Meiosis$381,084
R01 · FY2008 · HD · contact PI
The Role of Cks Proteins in Mammalian Meiosis$388,862
R01 · FY2007 · HD · contact PI
The Role of Cks Proteins in Mammalian Meiosis$400,475
R01 · FY2006 · HD · contact PI